Interscope

Interscope is a commercial-stage medical device company focused on advanced endoscopic resection tools. Its flagship product, the EndoRotor®, is a single device that simultaneously dissects, resects, and collects tissue, offering a novel approach for procedures like pancreatic necrosectomy and the treatment of difficult gastrointestinal lesions. The device holds both a 510(k) clearance for Endoscopic Powered Resection (EPR) and a De Novo authorization for Powered Endoscopic Debridement (PED) in the US, positioning it as a specialized tool for complex interventional gastroenterology. The company is actively conducting clinical studies to expand the device's indications, including for refractory dysplastic Barrett's esophagus.

The EndoRotor® System: a catheter-based, powered endoscopic resection device that simultaneously dissects, resects, and collects tissue via a rotating cutting tip with integrated suction.

Interscope competes with traditional endoscopic tools (snares, forceps, baskets) and other advanced techniques like Endoscopic Submucosal Dissection (ESD). For necrosectomy, it competes with other debridement devices and techniques. Its differentiation lies in its integrated cut-and-suction mechanism designed for control, efficiency, and completeness of resection in specific challenging scenarios.